Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Donegal (DGICA) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Donegal (DGICA) over the last 16 years, with Q3 2025 value amounting to $1.1 billion.

  • Donegal's Other Accumulated Expenses fell 181.08% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 181.08%. This contributed to the annual value of $1.1 billion for FY2024, which is 45.93% down from last year.
  • As of Q3 2025, Donegal's Other Accumulated Expenses stood at $1.1 billion, which was down 181.08% from $1.1 billion recorded in Q2 2025.
  • Donegal's 5-year Other Accumulated Expenses high stood at $1.1 billion for Q2 2024, and its period low was $997.0 million during Q1 2021.
  • In the last 5 years, Donegal's Other Accumulated Expenses had a median value of $1.1 billion in 2025 and averaged $1.1 billion.
  • In the last 5 years, Donegal's Other Accumulated Expenses surged by 1224.56% in 2021 and then tumbled by 283.05% in 2025.
  • Quarter analysis of 5 years shows Donegal's Other Accumulated Expenses stood at $1.1 billion in 2021, then increased by 4.03% to $1.1 billion in 2022, then grew by 0.46% to $1.1 billion in 2023, then fell by 0.46% to $1.1 billion in 2024, then decreased by 0.6% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.1 billion during Q1 2025.